Maynard Um
-
-
-
-
-
-
-
Theratechnologies (THTX) Reports Q2 results
-
-
-
-
-
-
-
Theratechnologies (THTX) Misses Q4 EPS by 16c
-
-
-
-
-
-
-
Theratechnologies (THTX) Unveils Study Design and Baseline Characteristics of PROMISE-US Trial of Ibalizumab
-
397,180 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

